Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0000950170-24-007904
Filing Date
2024-01-26
Accepted
2024-01-26 16:00:14
Documents
5

Document Format Files

Seq Description Document Type Size
1 424B5 424b5_sabs_fy24_atm_pros.htm 424B5 446068
2 GRAPHIC img155907947_0.jpg GRAPHIC 10022
3 GRAPHIC img155907947_1.jpg GRAPHIC 6542
4 GRAPHIC img155907947_2.jpg GRAPHIC 15634
5 GRAPHIC img155907947_3.jpg GRAPHIC 6542
  Complete submission text file 0000950170-24-007904.txt   501154
Mailing Address 2100 EAST 54TH STREET NORTH SIOUX FALLS SD 57104
Business Address 2100 EAST 54TH STREET NORTH SIOUX FALLS SD 57104 605-679-6980
SAB Biotherapeutics, Inc. (Filer) CIK: 0001833214 (see all company filings)

EIN.: 853899721 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-271768 | Film No.: 24567663
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)